Slope is the only end-to-end, vendor-agnostic platform for managing biospecimens and clinical inventory across the entire clinical research ecosystem. Trusted by 2,200+ sites in 23+ countries, Slope ...

Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...

Hospitals have more digital tools than ever, yet throughput continues to suffer. Since 2017, emergency department encounters lasting over eight hours have nearly doubled, inpatient units are strained ...

To counterbalance this, AI-driven predictive technology is helping clinicians to identify risk early enough for closer ...

Q2 2026 Earnings Call February 4, 2026 4:30 PM ESTCompany ParticipantsStephen Monroe - Vice President of Financial ...

Objective To compare the diagnostic accuracy of minipad collected menstrual blood versus clinician collected cervical samples to test for human papillomavirus (HPV) in the detection of cervical ...

Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates February 2, 2026 7:01 PM ESTCompany ParticipantsGary ...

By Vijay Kumar Malesu Why mismatched resistance thresholds between CLSI and EUCAST could be masking the true scale of ...

The Georgia carpet industry’s long use of PFAS, known as forever chemicals, polluted drinking water and the environment across swaths of the South.

It's the gold standard for analytics today, says Dr. Ryan Bosch of Acentra Health and a health system veteran – a proven model of care and data that can drive technical, clinical and business success.

Healthcare AI is surging — but inside clinics, many tools quietly stall. Physician executives explain why design, incentives, & governance matter more than algorithms.

NMPA: National Medical Products Administration, China’s regulatory body responsible for the approval of medical devices, cited in the context of product releases that impacted China gross margin.